Rosen Law Firm urges PRCT investors with over $100k losses to seek lead plaintiff role in securities fraud class action
Executive summary: Rosen Law Firm reminded investors who bought PROCEPT BioRobotics (PRCT) shares between Feb 28, 2024 and Feb 25, 2026 and suffered losses over $100k that they have until Sep 22, 2026 to seek lead plaintiff role in the securities fraud class action. The reminder highlights potential liability for PROCEPT and offers affected investors a mechanism to influence the litigation and possibly recover losses.
Who is involved: PROCEPT BioRobotics Corporation (NASDAQ: PRCT), Rosen Law Firm, investors with losses exceeding $100k, and the court overseeing the class action.
Likely next: Investors may submit lead plaintiff applications by the Sep 22 deadline; the court will then evaluate motions and could schedule further proceedings or settlement talks.
On September 11, 2026, Rosen Law Firm issued a reminder to purchasers of PROCEPT BioRobotics Corporation common stock between February 28, 2024 and February 25, 2026 who have incurred losses exceeding $100,000 that they may apply to serve as lead plaintiff in the pending securities fraud class action. The notice cites the upcoming September 22, 2026 deadline for lead plaintiff applications and references alleged violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5. The announcement adds to a series of similar alerts from the firm concerning other companies on the same day.
What's next — scenarios
Base: lead plaintiff appointed, litigation proceeds (50%)
Continued discovery and potential settlement negotiations affect PROCEPT's legal expenses and stock volatility.
- Court approves lead plaintiff application by Sep 30, 2026
- No settlement reached before Oct 15, 2026
Downside: no lead plaintiff appointed, case delayed or dismissed (30%)
Litigation stalls, reducing immediate legal costs but leaving investors without a lead representative.
- Court finds insufficient applications by Sep 22, 2026
- Defendant moves to dismiss for lack of adequate representation
Upside: strong lead plaintiff pushes for favorable settlement (20%)
Potential settlement could provide compensation to class members and limit prolonged litigation costs for PROCEPT.
- Lead plaintiff files motion for settlement by Oct 10, 2026
- PROCEPT agrees to mediation by Oct 20, 2026
What to watch
- September 22, 2026: deadline for lead plaintiff applications in PRCT class action
- Early October 2026: court hearing on lead plaintiff selection
- PRCT stock price reaction following any lead plaintiff announcement
- Any settlement announcement or mediation date in October 2026
Timeline
- — PRCT Deadline: PRCT Investors with Losses in Excess of $100K Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit (PR Newswire)
- — PRCT 12-DAY DEADLINE ALERT: PROCEPT BioRobotics Corporation Investors Alerted to September 22, 2026 Lead Plaintiff Deadline in Class Action Lawsuit (PR Newswire)
- — INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PROCEPT BioRobotics Corporation of Class Action Lawsuit and Upcoming Deadlines - PRCT (PR Newswire)
- — PRCT INVESTOR ALERT: PROCEPT BioRobotics Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Fraud Class Action Lawsuit (PR Newswire)
Analysis — what this means
Likely next events
- September 22, 2026: deadline for lead plaintiff applications in PRCT securities fraud class action
Sectors affected
- medical robotics
- healthcare technology
Regulatory implications
- Alleged violations of Section 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 could trigger SEC enforcement
Historical parallels
- September 5, 2026: Rosen Law Firm issued similar reminder for PRCT investors with over $100k losses
- September 1, 2026: prior alert noted lead plaintiff deadline of September 22, 2026 for PRCT class action
Key entities
Sources
- PRCT Deadline: PRCT Investors with Losses in Excess of $100K Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit — PR Newswire
- PRCT 12-DAY DEADLINE ALERT: PROCEPT BioRobotics Corporation Investors Alerted to September 22, 2026 Lead Plaintiff Deadline in Class Action Lawsuit — PR Newswire
- INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PROCEPT BioRobotics Corporation of Class Action Lawsuit and Upcoming Deadlines - PRCT — PR Newswire
- PRCT INVESTOR ALERT: PROCEPT BioRobotics Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Fraud Class Action Lawsuit — PR Newswire
Related cases
- ClaimsFiler reminds PROCEPT BioRobotics investors with over $100k losses of the Sept. 22 lead‑plaintiff deadline in an ongoing securities class action
- PROCEPT BioRobotics faces a securities fraud class action over undisclosed inventory issues that coincided with an roughly 18% drop in its share price
- Rosen Law Firm intensifies securities fraud litigation campaign with lead-plaintiff deadlines converging in September-October 2026 across multiple NASDAQ-listed companies
- PROCEPT BioRobotics faces a looming lead‑plaintiff deadline in a securities class action that could shape its legal exposure and investor sentiment
- PROCEPT BioRobotics faces a securities‑fraud class‑action deadline as investors with over $100k in losses are urged to seek lead plaintiff status
- PROCEPT BioRobotics faces a securities class action alleging Exchange Act violations, raising legal cost and investor uncertainty concerns